[A feasibility study of adjuvant therapy with capecitabine plus oxaliplatin (XELOX) for Japanese patients with advanced colorectal cancer].Tatsushi Shingai, Masahiko Yano, Masayuki Ohue et al.|PubMed|2015Cited by 0